POMALYST® (pomalidomide) is a thalidomide analogue indicated, in combination with dexamethasone, for adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.

BMS Access Support® Can Provide Patient Access
and Reimbursement Assistance
Bristol Myers Squibb is committed to helping patients gain access to their prescribed BMS medications. That’s why we offer BMS
Access Support. BMS Access Support provides resources to help patients understand their insurance coverage. In addition, we
can share information on sources of financial support, including co-pay assistance for eligible commercially insured patients.
How BMS Access Support May Help
Find out how BMS can work with patients and their healthcare providers to help access a prescribed BMS medication.
Financial Support Options
There may be programs and services that could help with the cost of treatment.
Learn about what options are available.
Additional Resources
We provide videos, tools, and other resources that may help with your access and
reimbursement needs.
Have Questions About Our Program or Possible Financial Support?
If you have questions about coverage for a prescribed BMS medication, BMS Access Support may be able to help. Patients and their healthcare provider can complete an enrollment form to learn about programs that may be of assistance. Visit our website or contact BMS Access Support to learn more.
Call Bristol Myers Squibb Access Support at
1-800-861-0048, 8 AM to 8 PM ET, Monday–Friday
Visit www.BMSAccessSupport.com
The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and the patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.